Clinical trial

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

NCT00987376

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-11-01

PhasePHASE1

Study timeline

Study start (unknown)2003-11-01Date precision: month

Registry last updated2016-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Diagnostic Imaging: C11 choline PET; C11 acetate PET; and MRI SpectroscopyDEVICE

Sponsors & collaborators

Mayo Cliniclead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00987376 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.